Barron's : Constellation Energy Has the Power That AI Needs. The CEO Is Making t

Constellation Energy Has the Power That AI Needs. The CEO Is Making the Most of It.
The company is about to become the world’s largest producer of electricity. Joe Dominguez tells us what to expect.

As the kingpins of AI scramble to secure electricity for their data centers, CEO Joe Dominguez has the goods. His Baltimore-based Constellation Energy is on the brink of producing more electricity than any company on earth.

Constellation produces most of its power with 21 nuclear reactors spread across several states, accounting for about a quarter of America’s nuclear generation. It also owns wind farms and hydroelectric plants. And it’s now acquiring one of the country’s biggest operators of natural-gas plants, Houston-based Calpine. When that deal closes, likely before year end, tens of millions of households across the country will depend on Constellation to keep the lights on.

Yet the company is far from a household name; in most places, its logo isn’t even on customer bills. When CEO Dominguez visited the White House in May, President Donald Trump was surprised to learn of Constellation’s sheer size. “That’s very impressive. I didn’t know that,” said Trump, before telling Dominguez, “You’re so modest.”

“That’s normally not said about me, Mr. President,” Dominguez replied.

Dominguez has reason to be immodest. Constellation was barely on anyone’s radar three years ago, when it spun out of utility Exelon. The utility held on to its regulated businesses, including transmission wires and customer service, while Constellation took over the power-generation business. Unlike regulated utilities, which control about half the country’s electricity generation, independent power producers like Constellation sell electricity directly to corporations, or to consumers at prices determined in competitive auctions. Power producers’ fortunes tend to rise and fall with supply and demand.

Constellation stock has followed electricity demand in one direction: up, up, up. Since its debut in 2022, the stock has rocketed more than 750%, giving the company a market value of $125 billion. That has come as Dominguez has signed eye-catching deals with both Meta Platforms
META and Microsoft to buy power from Constellation’s reactors for their artificial- intelligence data centers. Tech companies need the clean, reliable power Constellation produces, and they are willing to pay a premium for it. Any investor looking for ways to cash in on AI’s insatiable demand for power has invariably come across its name.

There’s good reason to keep believing in the company. AI’s demands for electricity look to be dwarfing anything from past eras. By some estimates, power demand from AI data centers could rise tenfold by 2030, an increase equivalent to adding 45 nuclear reactors. Dominguez is taking clear steps to make the most of that market and, equally important, to minimize the risks. As he knows well, a half-dozen major power companies have gone bankrupt over the past two decades chasing what they thought would be the next unstoppable wave of electricity demand. What if the AI wave crashes? Dominguez doesn’t intend to repeat that history.

Advertisement - Scroll to Continue


In a series of interviews with Barron’s over the past month, Dominguez laid out how Constellation can turn the company’s short-term sugar rush of revenue into a long-term growth story. First, he needs to be mindful of who has the real power in the industry. “The companies that I’m trying to call my clients are worth $3.5 trillion or $4 trillion. They could spend in a year the entire market capitalization of my company,” he says. “How do we chase that tiger down, now that we’ve got it by the tail?”

One answer is to bulk up. In January, Constellation agreed to buy privately held Calpine for $26.6 billion in stock and cash. Constellation stock has climbed over 30% since the announcement, a boon to Calpine’s owners. The deal is on track to close within the next few weeks, assuming the Department of Justice has no last-minute objections.

The acquisition will boost Constellation’s potential electricity output by some 80%. Calpine owns 61 natural-gas plants from coast to coast, big battery-storage installations, and the country’s largest geothermal resource, a steam-filled reservoir called the Geysers in northern California. It pumps out steam at such a steady rate that it could power all of San Francisco, Calpine says.

In all, the deal will leave Constellation as the face of modern power generation, providing enough electricity to serve over 40 million homes. It will sell much of that electricity to commercial and industrial companies, including data centers.

Dominguez, 63, is a new kind of energy CEO. Rather than coming up through exploration, refining, or plant management, he earned his spurs in the legal affairs side of the business, and then in governmental relations. That has left him well equipped to address the industry’s current challenges.

A son of Cuban immigrants raised in Union City, N.J., he studied engineering in college and went to law school with the intention of becoming a patent attorney. But he soon found something more exciting: He took a job as an assistant U.S. attorney in Philadelphia, prosecuting murder-for-hire and money-laundering cases.

It was his legal skills that got him in the door at Exelon in 2002. He became a problem-solver for a company with plenty of legal headaches, from badly delayed power-plant projects to superfund site cleanups. Some cases were literally radioactive. The state of Illinois sued Exelon after finding tritium in the water near one of its nuclear reactors.

Then as now, Dominguez had the sharp speaking style of a successful prosecutor, and he could break complicated concepts down into understandable terms, colleagues say. Soon the company put him in charge of governmental relations, where the controversies were no less heated. Exelon beat back proposals looking to freeze electricity rates in Illinois, and Dominguez helped get controversial nuclear-energy subsidies passed in Illinois and New York.

The same arguments that worked in New York and Illinois led to game-changing federal legislation. In 2022, the Inflation Reduction Act introduced tax subsidies for nuclear plants that effectively created a price floor for their power.

Those tax credits saved the nuclear industry from disappearing, one rusty reactor at a time. A dozen U.S. reactors shut down from 2012 to 2021, largely because they couldn’t compete in short-term power auctions against cheaper natural gas and renewables, despite their value as baseload electricity generators. But since the tax credits were approved in 2022, no more have closed—and two companies have even announced plans to reopen reactors that were already shut down. The tax credits are a major reason Constellation had the confidence starting in 2023 to say it can grow its base earnings by at least 10% a year through the end of the decade.

The nuclear subsidies survived Trump’s One Big Beautiful Bill, even as wind and solar credits were eliminated. Nuclear power is one of the few areas in energy that has maintained support through both Republican and Democratic administrations. The public, too, now likes nuclear power: The industry’s favorability rating climbed to 61% this year, up from 44% in 2016, according to Gallup.

Dominguez has emerged from all this as a leading ambassador for the industry. “He’s very smart, can explain complex subjects easily, and understands the whole energy system,” says Jamie Dimon, CEO of JPMorgan Chase, which advised Constellation on the Calpine deal. “He’s got gas and nuclear and renewables. To understand the give and take of all of those things” is particularly valuable, he adds.

“There’s a lot of regulatory morass surrounding the utility industry, especially surrounding nuclear plants. But Joe’s a very clear thinker, he cuts through the nonsense,” says Doug Kimmelman, founder of private-equity firm Energy Capital Partners, which is selling Calpine to Constellation.

Kimmelman also credits Dominguez with convincing Trump and his top energy staff of other policies, including speeding up permitting for nuclear reactors. “I think he single-handedly has educated [the president] on the benefits of nuclear,” adds Kimmelman, a large Republican donor who said he has spoken to Trump about Dominguez. The White House didn’t respond to a request for comment.

Dominguez’s own politics are harder to pigeonhole. He has donated money to politicians in both parties.

He praised Trump effusively at an Oval Office signing ceremony for nuclear executive orders in May, saying that the president’s Energy Dominance council has made permitting energy projects easier. “You’re the best at building big things,” he told Trump. And Dominguez has opposed some environmental rules, criticizing states whose net-zero carbon policies depend heavily on expanding solar and wind power. He considers that strategy unrealistic.

But he views climate change as an urgent issue that energy companies need to address head on, putting him at odds with the Trump administration. Dominguez publicly criticized power-plant owners who opposed emissions rules introduced in 2023 under the Biden administration. Now Trump is working on repealing all carbon emission standards for the power industry.

Trump may be reversing climate rules today, but Dominguez expects them to come back. Power companies that ignore their climate impacts will eventually face financial repercussions, he argues. “The fact that someone doesn’t want to talk about climate today doesn’t mean that climate isn’t being talked about every day with customers and in the boardroom,” he says.

Dominguez has an economic incentive to advocate for climate-friendly policies. The fact that Constellation’s nuclear reactors don’t emit CO2 is one reason their power is valued at a premium to coal and natural-gas plants. But by purchasing Calpine, Constellation will soon own one of the largest natural-gas fleets in the country, vastly expanding its emissions. Dominguez says the acquisition is consistent with his climate views. Calpine appealed to him partly because of its work on carbon capture, a process allowing it to capture the carbon dioxide emissions coming out of plants, liquefy them, and store them underground. If Constellation builds more natural-gas plants, he’d want them designed so they could be retrofitted with carbon-capture technology, he says.

“If climate has seen its day and it’s not coming back as part of American public policy, then we’re going to have made mistakes,” he says.


In that spirit, Constellation’s next acquisition target is likely to have a much lighter carbon footprint. Dominguez said last month that he’s keeping an eye out for renewable energy assets, which he expects to eventually be offered for sale at attractive prices because Trump and Congress cut subsidies for the industry. “You can’t only invest in things that are politically popular at the moment,” he says.

Dominguez has seen how political ties can lead to disastrous outcomes. His last job before the Exelon spinoff was as CEO of Commonwealth Edison, the Exelon-owned utility that serves Chicago. His predecessor in that role was convicted in a high-profile bribery case involving the Illinois Speaker of the House. Dominguez was questioned by prosecutors in the case but never charged. In fact, conspirators were overheard on a wiretap saying they “wouldn’t trust Joe” to agree to their scheme.

“In retrospect, I’m proud that that’s the way they thought of me,” Dominguez says. From that experience, he learned to be wary of political attachments. In the time it takes to build a nuclear plant, the president could change two or three times. “You’d better be prepared for that.”

It isn’t just politics that has Dominguez on his toes. Constellation’s ties to the AI boom are the biggest selling point for its stock—and its biggest potential risk. The stock plunged in January after Chinese AI company DeepSeek emerged, causing investors to question whether AI really needs so much power. The AI boom is by no means guaranteed, and all those data centers could outlive their usefulness before the bills to finance the power plants are paid off.

“Some people believe that hyperscaler AIs are going to be here forever,” says Jeff Rosenbaum, a partner at investment manager King Street who focuses on power. “Other people think that a hyperscaler box is going to be good for a couple of years while these large language models learn, and then you’re going to have huge pickleball facilities.”

Even if AI’s demand for electricity continues apace, Dominguez could face a special risk of his own. For Constellation to keep up with the Microsofts of the world, it may eventually need to build new reactors or gas plants—but Dominguez has limited experience in the construction phase of the business.

“I’m worried constantly about, am I ready for this next chapter?” Dominguez said in an interview in his office at the company’s Baltimore headquarters. His experience at Exelon was instructive in how construction delays and cost overruns can push power companies into debt spirals. “What I know about building power plants is 20 years dated, around a disastrous build in New England that started my career. I’m acutely aware of how bad it could go, and how consuming to the entire organization it can be.”

That “disastrous build” was a set of power plant projects in Massachusetts in the early 2000s that had been badly delayed, leading to legal action that Dominguez worked on. Exelon wasn’t the only company struggling at that time. It was a rough era for power producers. Demand for electricity was stagnant, and regulations were changing. In the 1990s and early 2000s, about half of U.S. states chose to deregulate their electricity markets, taking electricity generation out of the hands of monopoly utilities. A new crop of independent power producers raced to take market share, buying or building dozens of new plants. Several expanded too fast and ran into financial trouble. Calpine and NRG Energy both filed for bankruptcy protection in the early-to-mid 2000s. Others were outright frauds: One of Enron’s many business lines was power generation.

The electricity market today is much different than it was back then, but the risk of overbuilding persists. Some new companies, such as Texas-based Fermi, are essentially building power plants on spec, betting that tech companies will eventually pay up for their electricity.

One way Dominguez is managing the risk associated with adding power capacity is by expanding or updating the company’s existing assets rather than building new ones. The poster child for that strategy is Three Mile Island, the nuclear plant that was the site of a notorious 1979 meltdown. Constellation owns the reactor on that site that wasn’t involved in the accident. It was shut down in 2019 for economic reasons, but Constellation is working to turn it back on by 2027, and has contracted to sell the power to Microsoft for 20 years at a rate that analysts say is at least twice the going price for electricity in the area.

Dominguez’s office is sparsely decorated, but one of the few pictures on the wall is of Three Mile Island. The company is renaming it the Crane Clean Energy Center after former Exelon CEO Chris Crane, who elevated Dominguez to his current job. “Three Mile Island, although a horrible event, was the foundation for everything that’s good that has come subsequently,” he says.

Similarly, Meta agreed to buy power from a Constellation nuclear plant in Illinois for 20 years. Constellation intends to add additional power-generating capacity to the plant by upgrading the equipment, a strategy known as “uprating.” Dominguez thinks uprates could eventually add the equivalent of five or six large new nuclear reactors to Constellation’s fleet.

Constellation shareholders like these deals because they lock in above-average power prices for 20 years. Dominguez said on the company’s latest earnings call that he’s “past the seventh-inning stretch” on a similar agreement. In an interview last month, he said those talks are still on track, and new potential buyers are sniffing around for deals.

Another method Constellation is using to provide power to data centers is called curtailment. It works like this: For most of the year, power plants are underutilized, because there isn’t enough demand for their electricity. But on a few days each year—particularly during heat waves, when people are using air conditioners—the grid gets overtaxed. Some businesses are willing to curtail their electricity use during those hours for a price. Data centers that want 24/7 power are often willing to pay that price, Dominguez says. Constellation acts as a broker between those two parties and takes a small cut. Constellation thinks it can broker about one nuclear reactor worth of curtailment deals by December.

The upshot: The company’s earnings are on track to increase 22% next year, well ahead of the S&P 500’s 13.8%. But a lot of that growth is already reflected in the stock price. The stock trades at 32.9 times Constellation’s expected 2026 earnings, versus 20.8 for the S&P 500.

There’s another, perhaps stronger case for the shares: the replacement value of the company’s assets compared with the current market value. Its existing plants would be impossible to build at anywhere near the prices that Constellation and Calpine originally paid. The cost of building a new natural-gas plant has risen sharply and now stands around $2,500 per kilowatt. Building a new nuclear reactor is much pricier; the latest ones cost over $10,000 a kilowatt. Today, the combined enterprise value of Calpine and Constellation is around $150 billion—for a company that will control about 60 gigawatts worth of power capacity. That’s roughly $2,500 a kilowatt, which gives Constellation minimal credit for its higher-value nuclear reactors or the fact that its plants are already hooked up to the grid, a process that can take upstart developers five years to achieve.

Valuing the combined company based on a conservative estimate of how much it would cost to replace its assets suggests it’s worth quite a bit more—say, $2,500 for the natural-gas plants and $8,500 for the nuclear ones (one government estimate of eventual costs). Taking into account the full mix of Constellation and Calpine’s energy types, it would probably cost more than $4,000 a kilowatt to replace the assets. That’s 60% more than the two companies are valued at today.

“You’ve got a huge incumbency advantage having the megawatts today,” says Energy Capital Partners’ Kimmelman. Energy Capital agreed to be paid mostly in Constellation stock in the Calpine deal, and will be Constellation’s largest shareholder once the deal closes. “We have a big vote of confidence for Joe and what he’s doing,” he says. “Otherwise we wouldn’t be taking the shares.”

Investors are searching for the next hot energy stock, hoping to make quick money on the AI frenzy. Dominguez’s vision might not play out that fast, but he’s putting Constellation at the center of whatever comes next.

>>> US Close Dow +0.52% S&P +0.53% Nasdaq +0.52% Russell -0.60%

Closing Market Summary: Major averages cement solid week-to-date gains
The stock market recovered from some early instability as broad strength pushed the S&P 500 (+0.5%), Nasdaq Composite (+0.5%), and DJIA (+0.5%) higher, cementing solid week-to-date gains.

While many sectors spent the morning flipping between positive and negative territory, nine S&P 500 sectors ultimately finished with gains.

The consumer staples sector (+1.2%) led the way, supported by nearly all of its components trading higher and Kenvue (KVUE 15.29, +1.18, +8.36%) capturing the widest gains across S&P 500 names today, recovering over half of yesterday's losses that came after reports the company will face litigation in the U.K. for alleged links between its talc-based products and ovarian cancer.

The financials sector (+0.8%) also outperformed as it shook off some of yesterday's weakness. Regional banking names faced significant losses after Zions Bancorp (ZION 49.67, +2.74, +5.84%) disclosed $50 million in charge-offs linked to fraudulent loans, adding to recent lending and liquidity concerns throughout the industry. Many of those names rebounded at least slightly today, with the KBW Regional Bank ETF (KRE 59.08, +0.94, +1.61%) recovering a chunk of yesterday's retreat.

Support came from a slate of banking names that beat earnings expectations, including Truist (TFC 42.60, +1.51, +3.67%), Comerica (CMA 74.92, +1.07, +1.45%), and Fifth Third (FITB 40.89, +0.53, +1.31%).

Creditor names also traded higher as industry leader American Express (AXP 346.62, +23.50, +7.27%) reported another earnings beat and raised the low end of its FY25 EPS and revenue guidance.

While the information technology sector (+0.4%) finished near the bottom of the standings, its move into positive territory was pivotal to the stabilization of the major averages. Weakness among semiconductor names saw the PHLX Semiconductor Index close 0.3% lower (which was well above its session lows).

Oracle (ORCL 291.45, -21.55, -6.88%) also faced a steep loss after the company's AI World Conference, with investors seemingly focused on commentary that the company is willing to accelerate investments in the near term, potentially pressuring margins and near-term earnings.

Despite the various pressures the sector faced, its three largest components, NVIDIA (NVDA 183.22, +1.41, +0.78%), Microsoft (MSFT 513.58, +1.97, +0.39%), and Apple (AAPL 252.29, +4.84, +1.96%), all closed with gains.

Only the materials (-0.4%) and utilities (-0.4%) sectors finished lower.

Macro developments were quieter today. Treasury Secretary Scott Bessent will discuss trade with the Chinese Vice Premier He Lifeng this evening, and President Trump is still reportedly set to meet with Chinese President Xi over the coming weeks.

The government remains shut down, which prevented the release of any economic data today. Rate cut expectations remain high ahead of next week's delayed release of the September Consumer Price Index.

U.S. Treasuries finished the week on a lower note, lifting yields on longer tenors off their lowest levels since April while the 2-year yield climbed off its lowest level in over three years. The 2-year note yield settled up three basis points to 3.46%, and the 10-year note yield settled up three basis points to 4.01%.
  • Nasdaq Composite: +17.5% YTD
  • S&P 500: + 13.3% YTD
  • Russell 2000: +10.0% YTD
  • DJIA: +8.6% YTD
  • S&P Mid Cap 400: +3.3% YTD

WSJ : The Attempted Assassination of a Russian Dissident Is Foiled in France

The Attempted Assassination of a Russian Dissident Is Foiled in France
The alleged plot targeted Vladimir Osechkin, a human-rights activist in exile and a critic of Russian President Vladimir Putin

PARIS—French authorities detained four men suspected of plotting to kill a Russian dissident living in the country, antiterrorism prosecutors said on Friday.

Prosecutors didn’t give the name of the dissident, but Vladimir Osechkin, a Russian national, identified himself as the target of this plot in a phone interview on Friday. Osechkin heads Gulagu.net, a human-rights organization that came to prominence exposing corruption and torture in Russian prisons and now helps opponents of President Vladimir Putin’s government leave Russia.

“They hired professional mercenary killers,” he said from Biarritz, in southwestern France, adding that the Russian state has been trying to kill him for years.

French authorities said the four men, aged between 26 and 38, were taken into police custody on Monday. On Thursday, prosecutors pressed preliminary charges against them for participating in a terrorist criminal conspiracy, with the intent to prepare one or more crimes against individuals.

Thousands of Russians have left their homeland since Putin launched his invasion of Ukraine in 2022 and commenced a crackdown on opposition activists inside the country, passing laws that barred most forms of dissent and criminalized criticism of the war.

Many of those who have left have set up precarious new lives in Europe, often struggling to find work and living in perpetual fear of becoming targets of the Russian state. In March 2024, Leonid Volkov, a close aide of the late Russian opposition leader Alexei Navalny, was attacked outside his home in Vilnius, Lithuania. He blamed the Russian government for targeting him because of his work exposing corruption.

The new arrests in France come as President Trump prepares to meet Putin for talks on ending the war in Ukraine. The two leaders agreed during a phone call this week to hold a meeting in Budapest, at a date yet to be announced. Trump is meeting with Ukrainian President Volodymyr Zelensky on Friday at the White House.

Osechkin sought political asylum in France after leaving Russia under pressure from the Kremlin over his activism exposing abuse in Russia’s prisons. He has since published videos of torture in Russia’s penitentiary system and collected accounts from prison guards and Russian military deserters who are now giving testimony to international courts. He now lives under protection from the French government.

Osechkin has also facilitated the flight from Russia of active servicemen who refused to fight, publicizing their cases and sometimes helping organize accommodation and legal representation for them in European countries.

In 2022, Osechkin told police he had been the target of an assassination attempt at his home, after receiving death threats. Local prosecutors opened an investigation but said they found no evidence at the time of an assassination attempt. Osechkin said prosecutors played down the threat because media attention to the case was preventing him from living a normal life.

In a YouTube broadcast on Thursday, Osechkin said he regularly received information about Russian assassination attempts planned for him.

He said the most recent warnings were about plans to shoot him during a recording of one of his regular livestreams on YouTube, after the alleged assassins had scoped out his location in the south of France.

“This was supposed to happen live on air, as theatrically as possible,” he said to his one million followers on the video-sharing platform. “To sow fear among those who deal with investigations exposing the crimes of the Putin regime.”

Axios : Nvidia and TSMC unveil first Blackwell chip wafer made in U.S.

Nvidia and TSMC unveil first Blackwell chip wafer made in U.S.

Nvidia and TSMC will announce on Friday their first completed U.S.-made wafer that will eventually become Blackwell chips for AI purposes, Nvidia first tells Axios.

Why it matters: This milestone represents some of the first fruits of the Trump administration's push to build AI technology in the U.S., and stay ahead in the race to control the future of artificial intelligence.

Driving the news: Nvidia founder and CEO Jensen Huang visited TSMC's semiconductor manufacturing facility in Phoenix on Friday to announce the advance.

What they're saying: "Nvidia and TSMC are working together to build the infrastructure that powers the world's AI factories, right here in America," Nvidia said in a blog post.

"TSMC Arizona is expected to create thousands of high-tech jobs and attract a broad ecosystem of suppliers," Nvidia and TSMC said in a joint statement.

Yes, but: The wafer is a crucial first step in re-shoring critical chip production in the U.S., but there's still a long way to go before the country's chip demand could be free of dependency on companies and factories overseas.

The bottom line: Intense efforts to re-shore key parts of the AI economy are starting to pay off.

The Information : Nvidia, Broadcom and AMD Face New Risks From OpenAI Deals

Nvidia, Broadcom and AMD Face New Risks From OpenAI Deals
AMD has the most downside because its shares rallied on the deal, making it the most expensive of the three.

The Takeaway
  • AMD shares rallied 40% on OpenAI deal, becoming most expensive.
  • OpenAI’s projected $115 billion burn by 2029 adds risk.
  • Nvidia’s data center chips comprise nearly 90% of its revenue.

The deals keep coming for semiconductor firms and OpenAI. In the past month, Nvidia, Advanced Micro Devices and Broadcom have each reached very different agreements to supply chips to OpenAI.

The arrangements open up all three to the risk that OpenAI, which expects to burn $115 billion through 2029, can’t afford to keep its commitments. The deals pose different risks to each company’s business, but AMD faces the biggest downside because its shares have rallied more than 40% since the announcement of its deal last Monday.

Before the deal news came out, all three chipmakers were trading at around 32 times next year’s earnings before interest, taxes, depreciation and amortization. After the rally, AMD is now at 43 times next year’s Ebitda compared to Broadcom’s 33 times and Nvidia’s 27 times.

Broadcom’s announcement, which involves a partnership to develop custom chips with OpenAI, is the most clear-cut. Nvidia, in its deal, pledged to invest in OpenAI as its build-out of artificial intelligence data centers progresses. The structure funds OpenAI but increases Nvidia’s exposure to the risky startup.

AMD last week pledged to give up to 10% of its own stock to OpenAI, in the form of warrants, in exchange for OpenAI’s commitment to buy its AI chips. Both Nvidia’s plan to invest in OpenAI and OpenAI’s plan to invest in AMD will play out over time and are contingent on OpenAI actually using the chips. In AMD’s case, the chipmaker isn’t planning on putting up any cash up front, and it will only give OpenAI the final chunk of its warrants if its own stock price roughly triples first.

Investors in AMD worry about what will happen if OpenAI doesn’t grow as fast as expected. “The question is, if OpenAI overestimated demand for compute, who will they support?” said Jamie Meyers, who helps manage the holdings of the three stocks at $1.6 billion asset manager Laffer Tengler Investments. “We suspect the pecking order is Nvidia, Broadcom, AMD.”

AMD CEO Lisa Su told investors in a call on the day of the deal announcement that the deal’s structure would help align AMD’s incentives with OpenAI’s.

“OpenAI actually has to do a lot of work to make sure that our deployments are successful.…The more OpenAI deploys, the more revenue we get, and they get to share part of the upside,” Su said.

Nvidia’s deal to invest up to $100 billion in OpenAI should also boost its top line meaningfully. OpenAI might end up leasing the chips from Nvidia rather than buying them outright, which could reduce risk for Nvidia. Still, its stock is down slightly since the announcement. That’s likely because it has the most to lose if the broader AI buildout falters. In the most recent fiscal quarter, chips used in data centers, primarily for AI, made up almost 90% of its revenue.

AMD and Broadcom are better diversified. Just over 40% of AMD’s revenue in the most recent quarter came from data centers, up from around 20% in 2021. The rest of its sales come from selling chips for a wide variety of uses, including personal computers and industrial processes.

Broadcom gets just a third of its revenue from chips and other equipment for AI data centers. Its software unit accounts for just over 40% of sales, boosting its margins above those of other chipmakers.

Analysts and investors expect that AMD’s data center segment will continue to grow faster than its other businesses on account of its AI chip deals, making AI a key reason for AMD’s relatively high valuation.

In the last few years, “there have been periods where AMD has traded at a higher multiple than Nvidia because I think there was some anticipation that they’re a new entrant to the market, and there was a compelling view of their foray into this AI GPU market,” said John Vinh, a KeyBanc Capital Markets analyst.

The problem is, AMD’s high valuation means that some of its success in the AI GPU market is already priced into the stock. Vinh says he downgraded the chipmaker’s stock a few quarters ago from overweight to neutral. There are also signs of slowing sales momentum for AMD’s AI chips, said Vinh, who is nonetheless optimistic about the company’s new chip, coming next year.

The bullish case for AMD, Vinh explained, is that the company could someday carve out a 20% market share in AI chips by taking business from Nvidia, which analysts estimate has between 80% and 90% of the market. Still, Nvidia has the technological edge, which could limit AMD’s gains.


Broadcom, whose shares are up almost 10% since the deal, has another advantage over Nvidia and AMD that could protect it if OpenAI struggles. Broadcom designs its chips from scratch for its customers, who as a result are less likely to go back on their purchasing commitments. Nvidia and AMD sell the chips as finished products.

Nvidia’s grip on the AI chip industry might be tough to break in part because of the company’s software, used to program its chips. Foundation Capital investor Ashu Garg, who has invested in companies such as Databricks and Skyflow, says most of the engineers at companies he’s backed are familiar with Nvidia’s software and don’t want to switch to AMD’s equivalent. “They don’t want to learn something new,” Garg said. “They’re like, OK, [AMD systems are] 5% or 10% cheaper. So what?”

Nvidia’s technological advantages in the AI chip business are reflected in its pricing power. That’s surely one reason why AMD has a much lower gross margin—below 50%—than Nvidia and Broadcom, whose margins are around 70%.

At least for now, Nvidia’s technological edge suggests it should be trading at the highest valuation multiple of the three chipmakers rather than the lowest. In the same vein, AMD’s deal with OpenAI suggests it should be at the bottom of the list.

Still, all three stocks reflect, to varying degrees, the same underlying risk.

“We think over the next year or two, demand is going to materialize that OpenAI is going to take advantage of to continue building out [capacity],” said Laffer Tengler’s Meyers. “But in four or five years, could we be having a different conversation? Absolutely.”

FT : UK closes in on drug pricing deal with White House

UK closes in on drug pricing deal with White House
NHS likely to pay billions more for some medicines in exchange for lower tariffs on British pharma exports

Sir Keir Starmer’s government believes it is closing in on a major drug pricing deal with the White House, in which Britain would pay billions of pounds more to buy some medicines in exchange for the US imposing “low to zero” tariffs for UK pharmaceutical exports.

British officials say talks are at an advanced stage. The ultimate prize, they say, would be for zero tariffs for all drugs made in the UK. Some people briefed on the talks say the US could push for a tariff of 10 per cent.

Varun Chandra, Sir Keir Starmer’s chief business adviser, has been leading talks. “We are quite close,” said one London official. “There have been extensive talks over the last 10 days.

“The pharma companies are pushing for a better deal, but we’ve told the US this is as far as we can go. We are demonstrating that we are taking on board their concerns.”

The UK government has proposed increasing the value at which the NHS deems a medicine cost-effective by up to 25 per cent, according to two officials.

But pharma industry sources said any deal would also have to include changes to the UK’s tax on medicine sales, otherwise any additional upfront spending would be clawed back under the tax, which caps how much the NHS spends on drugs. 

Trump announced plans for a 100 per cent tariff on branded medicines imported into the US late last month, but has not yet followed up with an executive order. The EU has said that its pharma exports will only be subject to a 15 per cent tariff, in line with its broader trade deal. 

Chandra has made it clear that Britain is willing to increase its spending on medicines — long a source of contention with the Trump administration — with UK officials confirming this would be a “significant one-off shift”. This would disappoint industry, which is pushing for the valuation metric, known as a quality adjusted-life year, to keep moving up in line with inflation. 

Officials said even the one-off move would add billions of pounds a year to Britain’s drugs bill over time as new and innovative products come on to the market. But they added that the initial cost to the cash-strapped UK Treasury would “not be big billions”.

There is yet to be an agreement over how the new drugs bill would be funded, although some in the Treasury believe it should come out of the existing NHS budget. Reeves last year increased the total health and social care budget by £22bn.

Two industry sources familiar with the negotiations also said the US was likely to demand the UK commit to increasing the proportion of GDP the country spends on innovative medicines, possibly doubling from 0.3 to 0.6 per cent. The US spends about 0.8 per cent, according to data compiled by the Association for the British Pharmaceutical Industry. 

Reeves, speaking on a visit to Washington DC this week, said she wanted to make Britain a more attractive location for global pharma companies and she was prepared to increase the amount Britain spends on drugs.

“We do need to make sure that we are an attractive place for pharmaceuticals and that includes on pricing,” Reeves said. “But in return for that we want to see more investment flow. That also requires NHS Trusts to be more open and willing to facilitate those trials as well. 

“We are working very closely both with both the pharmaceuticals industry and with the US on negotiations around tariffs. We have been very successful with the US in negotiating lower tariffs than anywhere else in the world and we want that to be the case with pharmaceuticals as well.”